Delivery Order SPE2DB20D1109-SPE2DB25FN46C
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,875.00 delivery order contract is for the supply of 4,563,057,206 units of Albendazole 200 mg tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $1,265.76. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Albendazole 200 mg tablets. The contract has a period of performance through September 25, 2024 and is a firm fixed price agreement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,122.02, is for the delivery of 4,567,553,713 units of the drug Albendazole 200 mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award, valued at $15,911.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,510,594 units of the pharmaceutical drug Albendazole 200 mg Tablet. The award is a Delivery Order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.60 firm fixed-price delivery order is for the supply of 4,566,160,823 units of the medication Albendazole 200 mg tablets, with an ultimate completion date of October 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $2,266.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albendazole 200 mg tablets, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $30,066.40 firm-fixed-price delivery order is for the supply of 4,565,436,139 units of Albendazole 200 mg tablets. This contract is a continuation of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albendazole 200 mg tablets. The contract, valued at $1,997.46, has a performance period through January 16, 2025 and was awarded on a Firm Fixed Price basis. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $20,346.64 and is for the delivery of ALBENDAZOLE 200 MG TABLET 2S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This...
- This federal contract award is for the delivery of 4,566,712,710 units of albendazole 200 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the U.S. Department of Defense. The contract, valued at $4,740.57, was awarded to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FN46CDelivery Order
This federal contract award, valued at $1,463.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply 4,567,095,577 units of the medication Albendazole 200 mg Tablet. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization and a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company's federal contract awards demonstrate its extensive supply chain and distribution capabilities, supplying a broad spectrum of pharmaceutical and medical products across multiple federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/30/25 |